PDMI Stock Overview
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Paradigm Medical Industries, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 19,900.00% |
| 3 Month Change | n/a |
| 1 Year Change | 19,900.00% |
| 3 Year Change | -71.43% |
| 5 Year Change | 100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| PDMI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.0% |
| 1Y | 19,900.0% | -1.4% | 21.9% |
Return vs Industry: PDMI exceeded the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: PDMI exceeded the US Market which returned 24.9% over the past year.
Price Volatility
| PDMI volatility | |
|---|---|
| PDMI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PDMI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PDMI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | n/a | www.paradigm-medical.com |
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories.
Paradigm Medical Industries, Inc. Fundamentals Summary
| PDMI fundamental statistics | |
|---|---|
| Market cap | US$649.76k |
| Earnings (TTM) | -US$345.00k |
| Revenue (TTM) | US$757.00k |
0.0x
P/S Ratio0.0x
P/E RatioIs PDMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PDMI income statement (TTM) | |
|---|---|
| Revenue | US$757.00k |
| Cost of Revenue | US$228.00k |
| Gross Profit | US$529.00k |
| Other Expenses | US$874.00k |
| Earnings | -US$345.00k |
Last Reported Earnings
Mar 31, 2012
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PDMI perform over the long term?
See historical performance and comparison